TauroLock™-HEP500

TauroLock™-HEP500 is a catheter lock solution specifically designed to prevent infections and maintain patency in dialysis catheters. Approved for instillation into all central venous catheters (CVCs) and suitable for use in vascular access devices (VADs) during dialysis, this product combines taurolidine, 4% citrate, and 500 IU/mL of heparin. Taurolidine provides broad-spectrum antimicrobial protection against gram-positive and gram-negative bacteria, as well as fungi, including resistant strains like MRSA and VRE. The concentration of heparin, combined with citrate, ensures effective anticoagulation to prevent occlusions during dialysis treatments.

Designed to minimise occlusion rates throughout dialysis, TauroLock™-HEP500 can be used with venous vascular access devices, particularly in haemodialysis catheters. This lock solution prevents the formation of bacterial biofilm, protecting patients against catheter-related infections while ensuring a high patency rate.